Advertisement
Home Tags Vaccines

Tag: Vaccines

Human papillomavirus (HPV) vaccination appears to confer a high degree of protection from oral HPV infections

ASCO: Vaccination Tied to Substantial Reduction in Oral HPV

Vaccination may help prevent oral HPV infections linked to oral cancers, researcher says
More than half of eligible Americans traveling abroad don't get a measles vaccine

Few Eligible U.S. Travelers Getting Pre-Trip Measles Vaccine

Though the disease was eliminated in the U.S. in 2000, foreign travel can still bring it home today
A series of short videos focusing on increasing influenza

AAFP: Educational Videos Created to Boost Adult Vaccine Uptake

New videos focus on influenza, zoster, and pneumococcal vaccine uptake among adults
An experimental vaccine therapy shows promise in treating glioblastoma

Vaccine-Chemotherapy Combo Promising in Glioblastoma

Four of the 11 patients in study survived for more than five years after vaccine/chemo treatment
There is variation in influenza vaccination coverage by industry and occupation

Variation in Occupational Influenza Vaccination Coverage

Wide variation by state in vaccination coverage among tier 1 and health care personnel groups
Infants are far less likely to develop pertussis if their mother received a tetanus toxoid

Maternal Pertussis Vaccination Reduces Risk for Newborns

Benefit is dramatic for newborns who are too young to be vaccinated, researchers say
Influenza vaccination is associated with reduced risk of laboratory-confirmed influenza-associated death in children

Vaccination Tied to Reduced Risk of Flu-Linked Pediatric Death

Influenza vaccine effectiveness 51 percent among children with high-risk conditions, 65 percent overall
Exposure to the quadrivalent human papillomavirus vaccine during pregnancy is not associated with adverse pregnancy outcomes

Inadvertent HPV Vax Doesn’t Up Risk of Poor Pregnancy Outcomes

No increased risk of major birth defect, spontaneous abortion, preterm birth, low birth weight, SGA
After heterologous primary and booster vaccination schedule of the adenovirus type 26 vector vaccine encoding Ebola virus glycoprotein and the modified vaccinia virus Ankara vector vaccine

Immune Responses to Ebola Vaccines Persist at One Year

All active vaccine recipients maintained Ebola virus-specific immunoglobulin responses at day 360
Introduction of seven-valent and 13-valent pneumococcal conjugate vaccine correlated with a reduction in Streptococcus pneumoniae bacteremia

Post-PCV13 Drop in Streptococcus pneumoniae Bacteremia

As pneumococcal rates dropped, rates of E. coli, Salmonella spp, Staphylococcus aureus increased